A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
Status:
Completed
Trial end date:
2021-01-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if LY900014 compared to insulin lispro (Humalog), both in
combination with insulin glargine or insulin degludec, is safe and effective in participants
with type 2 diabetes (T2D).